248 related articles for article (PubMed ID: 21762456)
1. Common membrane trafficking defects of disease-associated dynamin 2 mutations.
Liu YW; Lukiyanchuk V; Schmid SL
Traffic; 2011 Nov; 12(11):1620-33. PubMed ID: 21762456
[TBL] [Abstract][Full Text] [Related]
2. Dynamin-2 mutations associated with centronuclear myopathy are hypermorphic and lead to T-tubule fragmentation.
Chin YH; Lee A; Kan HW; Laiman J; Chuang MC; Hsieh ST; Liu YW
Hum Mol Genet; 2015 Oct; 24(19):5542-54. PubMed ID: 26199319
[TBL] [Abstract][Full Text] [Related]
3. A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.
James NG; Digman MA; Ross JA; Barylko B; Wang L; Li J; Chen Y; Mueller JD; Gratton E; Albanesi JP; Jameson DM
Biochim Biophys Acta; 2014 Jan; 1840(1):315-21. PubMed ID: 24016602
[TBL] [Abstract][Full Text] [Related]
4. Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.
Koutsopoulos OS; Koch C; Tosch V; Böhm J; North KN; Laporte J
PLoS One; 2011; 6(11):e27498. PubMed ID: 22096584
[TBL] [Abstract][Full Text] [Related]
5. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
[TBL] [Abstract][Full Text] [Related]
6. Isoform and splice-variant specific functions of dynamin-2 revealed by analysis of conditional knock-out cells.
Liu YW; Surka MC; Schroeter T; Lukiyanchuk V; Schmid SL
Mol Biol Cell; 2008 Dec; 19(12):5347-59. PubMed ID: 18923138
[TBL] [Abstract][Full Text] [Related]
7. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
Tinelli E; Pereira JA; Suter U
Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
[TBL] [Abstract][Full Text] [Related]
8. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
[TBL] [Abstract][Full Text] [Related]
9. A noncanonical role for dynamin-1 in regulating early stages of clathrin-mediated endocytosis in non-neuronal cells.
Srinivasan S; Burckhardt CJ; Bhave M; Chen Z; Chen PH; Wang X; Danuser G; Schmid SL
PLoS Biol; 2018 Apr; 16(4):e2005377. PubMed ID: 29668686
[TBL] [Abstract][Full Text] [Related]
10. Dynamin-2 in nervous system disorders.
González-Jamett AM; Haro-Acuña V; Momboisse F; Caviedes P; Bevilacqua JA; Cárdenas AM
J Neurochem; 2014 Jan; 128(2):210-23. PubMed ID: 24102355
[TBL] [Abstract][Full Text] [Related]
11. Insights into wild-type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish.
Zhao M; Smith L; Volpatti J; Fabian L; Dowling JJ
Hum Mol Genet; 2019 Dec; 28(24):4186-4196. PubMed ID: 31691805
[TBL] [Abstract][Full Text] [Related]
12. Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells.
González-Jamett AM; Baez-Matus X; Olivares MJ; Hinostroza F; Guerra-Fernández MJ; Vasquez-Navarrete J; Bui MT; Guicheney P; Romero NB; Bevilacqua JA; Bitoun M; Caviedes P; Cárdenas AM
Sci Rep; 2017 Jul; 7(1):4580. PubMed ID: 28676641
[TBL] [Abstract][Full Text] [Related]
13. Dynamin 2 and human diseases.
Durieux AC; Prudhon B; Guicheney P; Bitoun M
J Mol Med (Berl); 2010 Apr; 88(4):339-50. PubMed ID: 20127478
[TBL] [Abstract][Full Text] [Related]
14. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
[TBL] [Abstract][Full Text] [Related]
15. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
[TBL] [Abstract][Full Text] [Related]
16. Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis.
Bitoun M; Durieux AC; Prudhon B; Bevilacqua JA; Herledan A; Sakanyan V; Urtizberea A; Cartier L; Romero NB; Guicheney P
Hum Mutat; 2009 Oct; 30(10):1419-27. PubMed ID: 19623537
[TBL] [Abstract][Full Text] [Related]
17. Correlative SICM-FCM reveals changes in morphology and kinetics of endocytic pits induced by disease-associated mutations in dynamin.
Ali T; Bednarska J; Vassilopoulos S; Tran M; Diakonov IA; Ziyadeh-Isleem A; Guicheney P; Gorelik J; Korchev YE; Reilly MM; Bitoun M; Shevchuk A
FASEB J; 2019 Jul; 33(7):8504-8518. PubMed ID: 31017801
[TBL] [Abstract][Full Text] [Related]
18. A centronuclear myopathy--dynamin 2 mutation impairs autophagy in mice.
Durieux AC; Vassilopoulos S; Lainé J; Fraysse B; Briñas L; Prudhon B; Castells J; Freyssenet D; Bonne G; Guicheney P; Bitoun M
Traffic; 2012 Jun; 13(6):869-79. PubMed ID: 22369075
[TBL] [Abstract][Full Text] [Related]
19. Dynamic instability of microtubules requires dynamin 2 and is impaired in a Charcot-Marie-Tooth mutant.
Tanabe K; Takei K
J Cell Biol; 2009 Jun; 185(6):939-48. PubMed ID: 19528294
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
